SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-07-078408
Filing Date
2007-10-31
Accepted
2007-10-31 14:23:23
Documents
10

Document Format Files

Seq Description Document Type Size
1 425 a07-27173_9425.htm 425 18271
2 GRAPHIC g271739mmi001.jpg GRAPHIC 32006
3 GRAPHIC g271739mmi002.jpg GRAPHIC 116940
4 GRAPHIC g271739mmi003.jpg GRAPHIC 73082
5 GRAPHIC g271739mmi004.jpg GRAPHIC 64501
6 GRAPHIC g271739mmi005.jpg GRAPHIC 56252
7 GRAPHIC g271739mmi006.jpg GRAPHIC 53098
8 GRAPHIC g271739mmi007.jpg GRAPHIC 55542
9 GRAPHIC g271739mmi008.jpg GRAPHIC 43339
10 GRAPHIC g271739mmi009.jpg GRAPHIC 32012
  Complete submission text file 0001104659-07-078408.txt   747501
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filed by) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-15006 | Film No.: 071202296
SIC: 2835 In Vitro & In Vivo Diagnostic Substances